Sanofi-Aventis, Johns Hopkins University to jointly research respiratory disease
PARIS (Thomson Financial) - Sanofi-Aventis and Johns Hopkins University’s school of medicine have signed a three-year collaboration agreement for research into respiratory and immuno-allergic diseases.
Sanofi and the school of medicine’s Division of Allergy and Clinical Immunology will work jointly to discover and develop new ways of treating respiratory disease, focusing in particular on severe asthma and chronic obstructive pulmonary disease, the French pharmaceutical company said in a statement.
helen.beresford@thomsonreuters.com
hem/jfr
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
Neither the Subscriber nor Thomson Financial News warrants the completeness or accuracy of the Service or the suitability of the Service as a trading aid and neither accepts any liability for losses howsoever incurred. The content on this site, including news, quotes, data and other information, is provided by Thomson Financial News and its third party content providers for your personal information only, and neither Thomson Financial News nor its third party content providers shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon.
By Muslim Rahman on Jul 20, 2008 in Health